Mirtazapine in Comorbid Major Depression and Alcohol Dependence: An Open-Label Trial
{{output}}
OBJECTIVE: This was a first pilot study evaluating the acute phase (8-week) efficacy of the antidepressant medication mirtazapine for the treatment of depressive symptoms and drinking of subjects with comorbid major depressive disorder and alcohol dependence (... ...